Thiopurine Enhanced All Maintenance (Team): Study Protocol for a Randomized Study to Evaluate the Improvement in Disease-Free Survival by Adding Very Low Dose 6-Thioguanine to 6-Mercaptopurine/Methotrexate-Based Maintenance Therapy in Pediatric and Adult Patients (0-45 Years) with Newly Diagnosed B-Cell Precursor or T-Cell Acute Lymphoblastic Leukemia Treated According to the Intermediate Risk-High Group of the Alltogether1 Protocol